real-world outcomes of autosct for multiple myeloma in the first-line setting
Published 1 year ago • 165 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:18
analysis of real-world outcomes in patients with b-all receiving tisagenlecleucel
-
1:30
real-world insight for myeloma
-
1:45
the real-world experience of dara-vtd in transplant-eligible multiple myeloma
-
9:36
what are the real-world outcomes following treatment with teclistamab in rrmm?
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
9:25
mgus diagnosis: a step-by-step approach
-
1:59
the rapid evolution of myeloma research & the importance of improving drug accessibility
-
1:53
the future of multiple myeloma treatment
-
2:25
the importance of real-world data in multiple myeloma
-
1:33
teclistamab for multiple myeloma in us hospitals: real-world data analysis
-
3:02
real-world safety and efficacy of cilta-cel in r/r multiple myeloma
-
1:05
real-world comparison of rvd vs d-rvd in newly diagnosed transplant-eligible multiple myeloma
-
3:00
moving away from allosct to cellular therapy in multiple myeloma: current and future outlooks
-
2:45
myeloma: real-world data
-
2:29
real-world experiences with ide-cel in r/r multiple myeloma
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
4:12
insight-mm: real-world analysis of dot with rd-based regimens in r/r myeloma
-
2:33
multiple myeloma coverage on vjhemonc!